Dennis Glick
Psychiatry · Greenbelt, MDNPI 1114981651
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,523 of the $4,025 with a category attached, or 87.5%. It is spread thinly across 23 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,309 and has fallen 97.3% since, to $63 in 2023. Among psychiatry clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$673
- Supernus Pharmaceuticals, Inc.$609
- Otsuka America Pharmaceutical, Inc.$438
- Sunovion Pharmaceuticals Inc.$345
- Lundbeck LLC$335
- Johnson & Johnson$263
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$50012%
- Food & beverage$3,52388%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $673 |
| Supernus Pharmaceuticals, Inc. | 2 | $609 |
| Otsuka America Pharmaceutical, Inc. | 26 | $438 |
| Sunovion Pharmaceuticals Inc. | 16 | $345 |
| Lundbeck LLC | 22 | $335 |
| Johnson & Johnson | 10 | $263 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $165 |
| Neos Therapeutics, LP | 11 | $162 |
| Shire North American Group Inc | 6 | $121 |
| MDD US Operations, LLC | 5 | $113 |
| Neurocrine Biosciences, Inc. | 7 | $111 |
| Indivior Inc. | 5 | $95 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $88 |
| Alkermes, Inc. | 5 | $88 |
| Ironshore Pharmaceuticals Inc. | 5 | $87 |
| Jazz Pharmaceuticals Inc. | 4 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| Adlon Therapeutics L.p. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 3 | $48 |
| Orexo US, Inc. | 3 | $47 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Vertical Pharmaceuticals, LLC | 2 | $24 |
| Alfasigma USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$120
- INVEGA SUSTENNA$116
- INVEGA TRINZA$116
- SPRAVATO$116
How this compares
$4,025 in reported general payments places this provider in the 90th percentile of 851 psychiatry providers in Maryland.
Other psychiatry in Greenbelt
- Jyoti BehlGreenbelt$9K
- John VaethBaltimore$2.1M
- Scott AaronsonBaltimore$334K
- Jamal FawazHagerstown$321K
- Thomas LaughrenRockville$283K
- Adam RothAnnapolis$210K
- Robert LehmanBaltimore$140K
- Karen AndersonBaltimore$117K
- Orlando DavisBaltimore$104K
- Paul LeberPotomac$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.